{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:12:46Z","timestamp":1791202366411,"version":"4.2.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":942,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Recent studies have found hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells (PBMCs) of the majority of presumed recovered subjects. We investigated this unexpected finding using samples from patients whose HCV RNA and anti-HCV status had been serially confirmed. HCV RNA was detected in PBMCs from 66 of 67 chronic HCV carriers. Subpopulation analysis revealed that the viral load (log copies\/106 cells) in B cells (4.14 \u00b1 0.71) was higher than in total PBMCs (3.62 \u00b1 0.71;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>&lt; 0.05), T cells (1.67 \u00b1 0.88;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>&lt; 0.05), and non-B\/T cells (2.48 \u00b1 1.15;<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>&lt; 0.05). HCV negative-strand RNA was not detected in PBMCs from any of 25 chronically infected patients. No residual viral RNA was detected in total PBMCs or plasma of 59 presumed recovered subjects (11 spontaneous and 48 treatment induced) using nested real-time polymerase chain reaction with a detection limit of 2 copies\/\u03bcg RNA (from \u02dc1 \u00d7 106 cells). PBMCs from 2 healthy HCV-negative blood donors became HCV RNA positive, with B-cell predominance, when mixed<\/jats:bold>\n                                 <jats:bold>\n                                    in vitro\n                                 <\/jats:bold>\n                                 <jats:bold>with HCV RNA\u2013positive plasma, thus passively mimicking cells from chronic HCV carriers. No residual HCV was detected in liver or other tissues from 2 spontaneously recovered chimpanzees.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>(1) HCV RNA was detected in PBMCs of most chronic HCV carriers and was predominant in the B-cell subpopulation; (2) HCV detected in PBMCs was in a nonreplicative form; (3) HCV passively adsorbed to PBMCs of healthy controls<\/jats:bold>\n                                 <jats:bold>\n                                    in vitro\n                                 <\/jats:bold>\n                                 <jats:bold>, becoming indistinguishable from PBMCs of chronic HCV carriers; and (4) residual HCV was not detected in plasma or PBMCs of any spontaneous or treatment-recovered subjects or in chimpanzee liver, suggesting that the classic pattern of recovery from HCV infection is generally equivalent to viral eradication.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.25921","type":"journal-article","created":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T04:53:12Z","timestamp":1340427192000},"page":"483-491","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["Investigation of Residual Hepatitis C Virus in Presumed Recovered Subjects"],"prefix":"10.1097","volume":"57","author":[{"given":"Kei","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Bare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Schechterly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco M.","family":"Marincola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey J.","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20241201","first-page":"6569","article-title":"Wkly Epidemiol R","volume":"72","year":"1997","journal-title":"ec"},{"key":"R2-9-20241201","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1126\/science.285.5424.26","article-title":"The scientific challenge of hepatitis C.","volume":"285","author":"Cohen","year":"1999","journal-title":"Science"},{"key":"R3-9-20241201","doi-asserted-by":"crossref","first-page":"996999","DOI":"10.1182\/blood-2002-10-3230","article-title":"Hepatitis C virus and Bcell nonHodgkin lymphomas: an Italian multicenter casecontrol study.","volume":"102","author":"Mele","year":"2003","journal-title":"Blood"},{"key":"R4-9-20241201","doi-asserted-by":"crossref","first-page":"20102017","DOI":"10.1001\/jama.297.18.2010","article-title":"Risk of nonHodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.","volume":"297","author":"Giordano","year":"2007","journal-title":"JAMA"},{"key":"R5-9-20241201","doi-asserted-by":"crossref","first-page":"665675","DOI":"10.1002\/hep.22706","article-title":"Occult hepatitis C: how convincing are the current data?","volume":"49","author":"Welker","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R6-9-20241201","doi-asserted-by":"crossref","first-page":"889900","DOI":"10.1093\/cid\/cir076","article-title":"Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more.","volume":"52","author":"Pearlman","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R7-9-20241201","doi-asserted-by":"crossref","first-page":"58675874","DOI":"10.1128\/JVI.78.11.5867-5874.2004","article-title":"Hepatitis C virus persistence after spontaneous or treatmentinduced resolution of hepatitis C.","volume":"78","author":"Pham","year":"2004","journal-title":"J Virol"},{"key":"R8-9-20241201","doi-asserted-by":"crossref","first-page":"106114","DOI":"10.1002\/hep.20518","article-title":"Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.","volume":"41","author":"Radkowski","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R9-9-20241201","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1053\/j.gastro.2006.04.015","article-title":"Kinetics and risk of de novo hepatitis B infection in HBsAgnegative patients undergoing cytotoxic chemotherapy.","volume":"131","author":"Hui","year":"2006","journal-title":"Gastroenterology"},{"key":"R10-9-20241201","doi-asserted-by":"crossref","first-page":"10881092","DOI":"10.1086\/432917","article-title":", Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir.","volume":"192","author":"Lee","year":"2005","journal-title":"J Infect Dis"},{"key":"R11-9-20241201","doi-asserted-by":"crossref","first-page":"17201722","DOI":"10.1002\/jmv.21257","article-title":"Immune suppression leading to hepatitis C virus reemergence after sustained virological response.","volume":"80","author":"Lin","year":"2008","journal-title":"J Med Virol"},{"key":"R12-9-20241201","doi-asserted-by":"crossref","first-page":"654660","DOI":"10.1111\/j.1872-034X.2010.00641.x","article-title":"Relapse of hepatitis C in a pegylatedinterferonalpha2b plus ribavirintreated sustained virological responder.","volume":"40","author":"Fujii","year":"2010","journal-title":"Hepatol Res"},{"key":"R13-9-20241201","first-page":"16911696","article-title":"Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.","volume":"334","author":"ConryCantilena","year":"1996","journal-title":"N Engl J Med"},{"key":"R14-9-20241201","doi-asserted-by":"crossref","first-page":"17171727","DOI":"10.1099\/vir.0.80882-0","article-title":"Continuous release of hepatitis C virus (HCV) by peripheral blood mononuclear cells and Blymphoblastoid cellline cultures derived from HCVinfected patients.","volume":"86","author":"Bare","year":"2005","journal-title":"J Gen Virol"},{"key":"R15-9-20241201","doi-asserted-by":"crossref","first-page":"636642","DOI":"10.1016\/S0016-5085(99)70185-X","article-title":"Realtime detection system for quantification of hepatitis C virus genome.","volume":"116","author":"Takeuchi","year":"1999","journal-title":"Gastroenterology"},{"key":"R16-9-20241201","doi-asserted-by":"crossref","first-page":"14461452","DOI":"10.1002\/hep.22184","article-title":"Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia.","volume":"47","author":"Bernardin","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R17-9-20241201","first-page":"594601","article-title":"No evidence of occult hepatitis C virus (HCV) infection in serum of HCV antibodypositive HCV RNAnegative kidneytransplant patients.","volume":"23","author":"Nicot","year":"2010","journal-title":"Transpl Int"},{"key":"R19-9-20241201","doi-asserted-by":"crossref","first-page":"14311441","DOI":"10.1002\/hep.22802","article-title":"Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro.","volume":"49","author":"MacParland","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R20-9-20241201","doi-asserted-by":"crossref","first-page":"27892793","DOI":"10.3748\/wjg.14.2789","article-title":"Occult persistence and lymphotropism of hepatitis C virus infection.","volume":"14","author":"Pham","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R21-9-20241201","doi-asserted-by":"crossref","first-page":"556562","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J Med"},{"key":"R22-9-20241201","doi-asserted-by":"crossref","first-page":"821829","DOI":"10.1053\/j.gastro.2008.05.044","article-title":"Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.","volume":"135","author":"Maylin","year":"2008","journal-title":"Gastroenterology"},{"key":"R23-9-20241201","doi-asserted-by":"crossref","first-page":"12671271","DOI":"10.1097\/QAD.0b013e3283391d11","article-title":"Clearance of hepatitis C virus RNA from serum in HIVhepatitis C virus coinfection indicates eradication from peripheral blood mononuclear cells.","volume":"24","author":"Page","year":"2010","journal-title":"AIDS"},{"key":"R24-9-20241201","doi-asserted-by":"crossref","first-page":"676685","DOI":"10.1053\/j.gastro.2010.10.048","article-title":"Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses.","volume":"140","author":"Veerapu","year":"2011","journal-title":"Gastroenterology"},{"key":"R25-9-20241201","doi-asserted-by":"crossref","first-page":"729738","DOI":"10.1002\/hep.22694","article-title":"Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5year followup of 150 patients.","volume":"49","author":"George","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R26-9-20241201","doi-asserted-by":"crossref","first-page":"14121419","DOI":"10.1002\/hep.22487","article-title":"Interpretation of positive transcriptionmediated amplification test results from polymerase chain reactionnegative samples obtained after treatment of chronic hepatitis C.","volume":"48","author":"Morishima","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R27-9-20241201","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/hep.21283","article-title":"Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences.","volume":"44","author":"Blackard","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R28-9-20241201","doi-asserted-by":"crossref","first-page":"816822","DOI":"10.1111\/j.1365-2516.2008.01773.x","article-title":"Evidence of occult HCV genotypes in haemophilic individuals with unapparent mixed infections.","volume":"14","author":"Parodi","year":"2008","journal-title":"Haemophilia"},{"key":"R29-9-20241201","doi-asserted-by":"crossref","first-page":"827835","DOI":"10.1086\/323391","article-title":"Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver.","volume":"184","author":"Boisvert","year":"2001","journal-title":"J Infect Dis"},{"key":"R30-9-20241201","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00430-008-0099-9","article-title":"Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCVinfected patients.","volume":"198","author":"Riva","year":"2009","journal-title":"Med Microbiol Immunol"},{"key":"R31-9-20241201","doi-asserted-by":"crossref","first-page":"18431850","DOI":"10.1002\/hep.22550","article-title":"Cell cultureproduced hepatitis C virus does not infect peripheral blood mononuclear cells.","volume":"48","author":"Marukian","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R32-9-20241201","doi-asserted-by":"crossref","first-page":"14331441","DOI":"10.1046\/j.1537-2995.2003.00475.x","article-title":"HCV viral load in antiHCVreactive donors and infectivity for their recipients.","volume":"43","author":"Operskalski","year":"2003","journal-title":"Transfusion"},{"key":"R33-9-20241201","doi-asserted-by":"crossref","first-page":"688693","DOI":"10.1053\/jhep.2002.31870","article-title":"Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin.","volume":"35","author":"McHutchison","year":"2002","journal-title":"HEPATOLOGY"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.25921","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201302000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:05:22Z","timestamp":1733061922000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201302000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.25921","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}